NCT07459543 2026-03-09A Study To Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Untreated, Unresectable or Metastatic Melanoma Participants In IndiaBristol-Myers SquibbPhase 4 Not yet recruiting30 enrolled
NCT04657991 2026-03-02A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic MelanomaPfizerPhase 3 Active not recruiting257 enrolled
NCT06585410 2026-02-25Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell CarcinomaRegeneron PharmaceuticalsPhase 3 Recruiting369 enrolled
NCT07429123 2026-02-24Using an Artificial Intelligence Medical Device to Help Primary Care Practitioners Identify and Manage Skin Conditions (Tumor, Inflammatory, and Infectious Diseases) in Adult Patients at Pozuelo and Majadahonda Health CentersAI Labs Group S.LCompleted131 enrolled
NCT06870487 2026-02-19A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced CancersPfizerPhase 1 Active not recruiting6 enrolled